Hunan Friendship & Apollo Commercial (002277.SZ): Restructuring matter to be reviewed at a meeting on November 12
Hunan Friendship & Apollo Commercial (002277.SZ) announced that the company plans to acquire 100% equity of Shenzhen Shangyangtong Technology Co., Ltd. from 37 counterparties, including Jiang Rong, Jiang Feng, Xiao Sheng'an, Shenzhen Zishu Management Consulting Partnership (Limited Partnership), and Shenzhen Qingshu Investment Partnership (Limited Partnership), by issuing shares and paying cash, while also raising supporting funds. According to the "Announcement of the 19th Deliberation Meeting of 2026 of the Merger, Acquisition and Restructuring Review Committee of the Shenzhen Stock Exchange," the Shenzhen Stock Exchange Merger, Acquisition and Restructuring Review Committee is scheduled to hold the 19th Merger, Acquisition and Restructuring Review Committee deliberation meeting of 2026 on November 12, 2026, to review the company's proposed transaction.
Hunan Friendship & Apollo Commercial (002277.SZ) announced that the company plans to acquire 100% equity of Shenzhen Shangyangtong Technology Co., Ltd. from 37 counterparties, including Jiang Rong, Jiang Feng, Xiao Sheng'an, Shenzhen Zishu Management Consulting Partnership (Limited Partnership), and Shenzhen Qingshu Investment Partnership (Limited Partnership), by issuing shares and paying cash, while simultaneously raising supporting funds. According to the "Announcement of the 19th Deliberation Meeting in 2026 of the Merger, Acquisition and Restructuring Review Committee of the Shenzhen Stock Exchange," the Merger, Acquisition and Restructuring Review Committee of the Shenzhen Stock Exchange is scheduled to hold the 19th Merger, Acquisition and Restructuring Review Committee deliberation meeting in 2026 on November 12, 2026, to review the company's transaction.
Related Articles
At the CIIE, JD Health signed agreements with more than 20 brands including Pfizer and Merck; in the first three quarters, it launched more than 100 new drugs, and JD HEALTH (06618) remains firmly the largest pharmaceutical retail platform in China.
HK Stock Market Move | AI hardware stocks opened sharply lower; Democrats sweep Congress, AI regulatory concerns escalate, and the U.S. stock market crash spreads to Asia-Pacific markets.
HK Stock Market Move | LI NING (02331) Opens Nearly 4% Higher; Company's RMB6 Billion Special Dividend Takes Effect, Continues to Advance Professional Sports and Brand Building
At the CIIE, JD Health signed agreements with more than 20 brands including Pfizer and Merck; in the first three quarters, it launched more than 100 new drugs, and JD HEALTH (06618) remains firmly the largest pharmaceutical retail platform in China.
HK Stock Market Move | AI hardware stocks opened sharply lower; Democrats sweep Congress, AI regulatory concerns escalate, and the U.S. stock market crash spreads to Asia-Pacific markets.
HK Stock Market Move | LI NING (02331) Opens Nearly 4% Higher; Company's RMB6 Billion Special Dividend Takes Effect, Continues to Advance Professional Sports and Brand Building
